2020
Article in NZZ am Sonntag: "The world needs new antibiotics".
Article in NZZ am Sonntag giving a comprehensive overview of the problem of combatting multiresistant bacteria including activities within the NCCR Antiresist: "The world needs new antbiotics".
InSphero - BEL Collaboration as case study at Basel Area workshop
Collaboration between spinoff InSphero AG and BEL or BSSE served as case study at workshop on academic industry collaborations in Basel Area.
BEL paper as Nature Methods "Research Highlight"
BEL paper in Nature Communications on high-density microelectrode arrays with dual-mode capabilities covered in Nature Methods as "Research Highlight".
NCCR "Antiresist" at Swiss Innovation Forum 2020
Movie on innovation in fighting resistance against antibiotics within the NCCR "Antiresist" including BEL contribution presented at Swiss Innovation Forum 2020.
Microfluidic system to study drug-drug interactions in vitro
Increasing drug-drug interactions in patients, treated with multiple medicines, require new methods to detect such complications. We developed a microfluidic in-vitro system that enables qualitative and quantitative assessments.
New dual-mode microelectrode system published in "Nature Communications"
New CMOS microelectrode system, featuring two simultaneously operated readout modes - full frame and switch matrix - for studying electrical activity and interaction of thousands of neuronal cells.
BEL contribution to article on retina organoids in "Cell"
BEL contributed large-scale electrophysiological measurements and corresponding data analysis to characterization of light-sensitive human retinal organoids, developed by Roska group at IOB. Results have been published in journal Cell.
Microtechnology enables physiologically relevant experiments
BEL Contribution to "Views" in Journal Cell Systems on how microfluidic and microfabrication approaches can contribute to enhance physiological relevance of experiments in biology and biomedicine.
Spinoff MaxWell Biosystems again among Top 100 Swiss startups
BEL spinoff, MaxWell Biosystems AG, founded 2016, reached rank 59 in the Swiss Top 100 Startup Competition 2020. MaxWell was listed as Biotech company.
BEL technology licensed to InSphero
License agreement for Akura™ Flow organ-on-a-chip platform concluded between ETH Zurich, Bio Engineering Laboratory, and InSphero AG.
Outstanding Paper Award of "Microsystems & Nanoengineering"
Outstanding Paper Award of Microsystems & Nanoengineering to P. Misun and co-authors for paper"Multi-analyte Biosensor Interface for Real-time Monitoring of 3D Microtissue Spheroids in Hanging-drop Networks".
Microfluidic platform for diabetes drug testing covered in ETH Industry News
Article on new microfluidic testing platform that will help diabetes researchers to find new drugs and to get deeper insights into underlying biological mechanisms in ETH Industry News.
Use of electrical impedance to screen for new antiparasitic drugs
As current drug screening methods are hampered by low throughput and potential subjectivity in parasite-phenotype evaluation, electrical impedance platform and method to screen for drugs against parasites, such as Schistosoma mansoni, has been developed.
BEL CMOS chip integral part of wire-bundle system for in-vivo measurements
New paper in Science Advances describing massively parallel microwire arrays for in-vivo neural recording includes CMOS high-density microelectrode-array chips developed at BEL.
New BEL coworker Alessio Buccino featured in BSSE news
New ETH postdoctoral fellow in our group, working on computational modeling of neuronal networks, Alessio Buccino, was interviewed for the News page of the Department BSSE.